Clinica Doctor Balcangiu-Stroescu

Type 2 Diabetes – symptoms and signs that may indicate the disease

Type 2 Diabetes – symptoms and signs that may indicate the disease
Useful information
March 17, 2026Andra-Elena Balcangiu-Stroescu

What is Type 2 Diabetes

Type 2 diabetes is a metabolic disease characterized by an increase in blood glucose levels.

Normally, insulin allows glucose from the blood to enter cells, where it is used to produce energy. In type 2 diabetes, insulin resistance develops, which means that cells no longer respond efficiently to its action.

As a result, glucose remains in the blood and blood glucose levels rise.

Common Symptoms of Type 2 Diabetes

Symptoms of type 2 diabetes can appear gradually and may sometimes be mild. Among the most common manifestations are:

Excessive Thirst

Intense thirst is one of the common symptoms of diabetes. Elevated blood glucose causes the body to eliminate more water through urine, which can lead to dehydration and the onset of thirst.

Frequent Urination

People with diabetes may notice they urinate more frequently, including during the night. This occurs because the kidneys attempt to eliminate excess glucose from the blood.

Fatigue

Persistent fatigue is another possible symptom. When glucose cannot be used efficiently by cells, the body does not produce sufficient energy.

Blurred Vision

Elevated blood glucose levels can temporarily affect the lens of the eye, causing blurred vision.

Slow Wound Healing

In people with diabetes, wounds and cuts may heal more slowly. Impaired circulation and elevated blood glucose levels can slow the healing process.

Recurrent Infections

Skin, urinary, or fungal infections may occur more frequently in people with diabetes.

Other Signs That May Appear

In addition to classic symptoms, some people may present other manifestations, such as:

  • increased sensation of hunger
  • tingling or numbness in the hands and feet
  • dry skin
  • dry mouth
  • appearance of dark patches at skin fold levels (acanthosis nigricans)

These signs may suggest insulin resistance.

Risk Factors for Type 2 Diabetes

Certain people have a higher risk of developing type 2 diabetes.

Risk factors include:

  • overweight or obesity
  • sedentary lifestyle
  • family history of diabetes
  • arterial hypertension
  • dyslipidemia (elevated cholesterol)
  • age over 45 years

People who present these risk factors should have their blood glucose checked periodically.

How the Diagnosis is Established

The diagnosis of type 2 diabetes is based on blood tests that measure blood glucose levels.

The most common tests are:

  • fasting blood glucose
  • glycated hemoglobin (HbA1c)
  • oral glucose tolerance test

The doctor will interpret the test results and establish the diagnosis.

The Importance of Early Diagnosis

Early detection of type 2 diabetes is very important because it allows treatment to begin and lifestyle changes to be adopted.

Blood glucose control reduces the risk of complications such as:

  • cardiovascular disease
  • kidney damage
  • diabetic neuropathy (nerve damage)
  • vision impairment

Conclusion

Type 2 diabetes can have subtle symptoms or may progress for a long period without obvious manifestations. Excessive thirst, frequent urination, fatigue, and recurrent infections are among the most common signs of this condition.

If you notice such symptoms or have risk factors for diabetes, it is recommended to perform the necessary tests and seek medical consultation.

Early diagnosis and appropriate treatment can contribute to maintaining good health and preventing long-term complications.

Also Read

Related Articles

A single injection for cholesterol — from dreams to first human results
Useful information

A single injection for cholesterol — from dreams to first human results

A Phase 1 trial published in the New England Journal of Medicine (November 2025) brings remarkable results: a single infusion of CTX310, a CRISPR-Cas9 therapy developed by Cleveland Clinic and CRISPR Therapeutics, reduced LDL cholesterol by up to 49% and triglycerides by up to 55% in patients with refractory dyslipidemia — without serious adverse events. The mechanism is unique: instead of blocking a protein or interfering with its mRNA, CTX310 permanently edits the ANGPTL3 gene in hepatic cells, mimicking a natural mutation associated with reduced cardiovascular risk throughout life. The therapy is currently in Phase 1b clinical stage, with updates expected in the second half of 2026. It is not approved and does not replace current treatments. Read the full article for clinical context, comparison with statins and PCSK9 inhibitors, and what these data mean for patients. Medical Disclaimer This article presents results from a Phase 1 clinical trial in an early-stage research phase. The therapy described is not approved and is not available as standard treatment. The information is for educational purposes only. Consult your physician for any medical decision.

June 1, 2026Andra-Elena Balcangiu-Stroescu

Ready to schedule?

Book an appointment online or call us directly.

+40 747 777 107